• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Research and Markets: GSK's Fendrix (Prophylactic Hepatitis B Virus Vaccines) Market 2014- Forecast Opportunities to 2022

    Research and Markets: GSK's Fendrix (Prophylactic Hepatitis B Virus Vaccines) Market 2014- Forecast Opportunities to 2022

  2. Update on GSK ’S MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Non-Small Cell Lung Cancer

    Update on GSK ’S MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Non-Small Cell Lung Cancer

  3. ADR Shares End Mixed; RBS Shares Active

    ADR Shares End Mixed; RBS Shares Active

  4. UPDATE: FTSE rises for second day as miners push higher

    UPDATE: FTSE rises for second day as miners push higher

  5. FTSE rises for second day as miners push higher

    FTSE rises for second day as miners push higher

  6. Top 10 Dividend-Yielding Stocks of Our Ultimate Stock-Pickers

    Our top managers continue to focus on higher-quality businesses rather than seeking out bargains in a market that (in many of their minds) has become fully valued.

  7. Makings of a Wide Moat in Diabetes Care

    Novel products will allow drug firms to achieve price premiums on diabetes drugs in the U.S. and at least retain level pricing internationally.

  8. NetScientific Partners with Peter Thiel’s Breakout Labs to Increase Support for Companies at the Forefront of Scientific Innovation

    NetScientific Partners with Peter Thiel’s Breakout Labs to Increase Support for Companies at the Forefront of Scientific Innovation

  9. Avoid Medicare Advantage Plans

    GlaxoSmithKline GSK reported solid second-quarter results on Wednesday that were largely in line with our expectations, and we don't anticipate any changes to our fair value estimate. Sales increased 10% from the prior year driven by strong sales of asthma medicine Advair, diabetes medicine ...

  10. These Foreign Stocks Are Medalist Fund Favorites

    More than a dozen analyst-approved foreign large-cap funds own these names.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.